|
Market Closed -
Nasdaq
02:30:00 19/11/2026 am IST
|
5-day change | 1st Jan Change | ||
| 11.25 USD | -0.71% |
|
+10.40% | +82.93% |
| 13/11 | ImmuCell Corporation, Q3 2026 Earnings Call, Nov 13, 2026 | |
| 13/11 | ImmuCell Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IMMUCELL CORPORATION | Other Pharmaceuticals | -0.71% | +10.40% | +82.93% | +146.71% | +25.98% | 10Cr |
- Stock Market
- Stocks
- ICCC Stock
- Charts ImmuCell Corporation
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
















